BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 31054837)

  • 1. Association of non-alcoholic fatty liver disease with microvascular complications of type 2 diabetes.
    Afarideh M; Aryan Z; Ghajar A; Ganji M; Ghaemi F; Saadat M; Heidari B; Mechanick JI; Esteghamati A
    Prim Care Diabetes; 2019 Dec; 13(6):505-514. PubMed ID: 31054837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease and incidence of microvascular complications of diabetes in patients with type 2 diabetes: a prospective cohort study.
    Deravi N; Dehghani Firouzabadi F; Moosaie F; Asadigandomani H; Arab Bafrani M; Yoosefi N; Poopak A; Dehghani Firouzabadi M; Poudineh M; Rabizadeh S; Kamel I; Nakhjavani M; Esteghamati A
    Front Endocrinol (Lausanne); 2023; 14():1147458. PubMed ID: 37342261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.
    Lv WS; Sun RX; Gao YY; Wen JP; Pan RF; Li L; Wang J; Xian YX; Cao CX; Zheng M
    World J Gastroenterol; 2013 May; 19(20):3134-42. PubMed ID: 23716995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conflicting interactions of apolipoprotein A and high density lipoprotein cholesterol with microvascular complications of type 2 diabetes.
    Aryan Z; Afarideh M; Ghajar A; Esteghamati S; Esteghamati A; Nakhjavani M
    Diabetes Res Clin Pract; 2017 Nov; 133():131-141. PubMed ID: 28934670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications.
    Ciardullo S; Muraca E; Perra S; Bianconi E; Zerbini F; Oltolini A; Cannistraci R; Parmeggiani P; Manzoni G; Gastaldelli A; Lattuada G; Perseghin G
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32049637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Non-Alcoholic Fatty Liver Disease and Diabetes-Related Microvascular Complications: A Retrospective Cross-Sectional Study of Hospitalized Patients.
    Wen X; Zhou X; Chen D; Cheng J; Ji L
    Endocr Pract; 2022 Mar; 28(3):304-309. PubMed ID: 33601024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship Between Serum Zinc Level and Microvascular Complications in Patients with Type 2 Diabetes.
    Luo YY; Zhao J; Han XY; Zhou XH; Wu J; Ji LN
    Chin Med J (Engl); 2015 Dec; 128(24):3276-82. PubMed ID: 26668140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
    Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S
    Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the relationship between non-alcoholic fatty liver disease and diabetic complications.
    Yan LH; Mu B; Guan Y; Liu X; Zhao N; Pan D; Wang SZ
    J Diabetes Investig; 2016 Nov; 7(6):889-894. PubMed ID: 27181828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sectional analysis of adult diabetes type 1 and type 2 patients with diabetic microvascular complications from a German retrospective observational study.
    Happich M; Breitscheidel L; Meisinger C; Ulbig M; Falkenstein P; Benter U; Watkins J
    Curr Med Res Opin; 2007 Jun; 23(6):1367-74. PubMed ID: 17559744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients.
    Targher G; Bertolini L; Rodella S; Zoppini G; Lippi G; Day C; Muggeo M
    Diabetologia; 2008 Mar; 51(3):444-50. PubMed ID: 18058083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of cell adhesion molecules and selectins (VCAM-1, ICAM-1, E-selectin, L-selectin, and P-selectin) with microvascular complications in patients with type 2 diabetes: A follow-up study.
    Siddiqui K; George TP; Mujammami M; Isnani A; Alfadda AA
    Front Endocrinol (Lausanne); 2023; 14():1072288. PubMed ID: 36843591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes.
    Mantovani A; Rigolon R; Mingolla L; Pichiri I; Cavalieri V; Salvotelli L; Stoico V; Zoppini G; Bonora E; Targher G
    J Diabetes Complications; 2017 Jun; 31(6):1021-1026. PubMed ID: 28254449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Alcoholic Fatty Liver Disease and Associated Factors among Type 2 Diabetic Patients in Southwest Ethiopia.
    Zawdie B; Tadesse S; Wolide AD; Nigatu TA; Bobasa EM
    Ethiop J Health Sci; 2018 Jan; 28(1):19-30. PubMed ID: 29622904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrarenal arterial resistance is associated with microvascular complications in Chinese type 2 diabetic patients.
    Liu KH; Chu WC; Kong AP; Ko GT; Ma RC; Chan JW; So WY; Luk AO; Cheung KK; Ozaki R; Ahuja AT; Chan JC
    Nephrol Dial Transplant; 2013 Mar; 28(3):651-8. PubMed ID: 23223219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus.
    Katsiki N; Anagnostis P; Kotsa K; Goulis DG; Mikhailidis DP
    Curr Pharm Des; 2019; 25(18):2051-2059. PubMed ID: 31298151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Alcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: Role of Circulating Branched-Chain Amino Acids.
    van den Berg EH; Flores-Guerrero JL; Gruppen EG; de Borst MH; Wolak-Dinsmore J; Connelly MA; Bakker SJL; Dullaart RPF
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30917546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: a 10-year follow-up study.
    Garofolo M; Gualdani E; Giannarelli R; Aragona M; Campi F; Lucchesi D; Daniele G; Miccoli R; Francesconi P; Del Prato S; Penno G
    Cardiovasc Diabetol; 2019 Nov; 18(1):159. PubMed ID: 31733651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients.
    Giandalia A; Romeo EL; Ruffo MC; Muscianisi M; Giorgianni L; Forte F; Cucinotta D; Russo GT
    Prim Care Diabetes; 2017 Jun; 11(3):226-232. PubMed ID: 28017576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between increased left atrial volume and microvascular complications in patients with type 2 diabetes.
    Bonapace S; Rossi A; Lipari P; Bertolini L; Zenari L; Lanzoni L; Canali G; Molon G; Mantovani A; Zoppini G; Bonora E; Barbieri E; Targher G
    J Diabetes Complications; 2015 Aug; 29(6):822-8. PubMed ID: 26050564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.